NGL Fine-Chem

Stock Price vs Company Growth
1d
0.2%
1w
0.8%
1m
8.4%
3m
35.7%
6m
49.2%
1y
50.4%
5y
28.7%
10y
30.5%
all
25.9%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec18Jun20Dec21Jun23Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

1,060 0.2%
963
2,031
Company Overview

Sales
373 Cr
Growth: 17.7%
Profit after Tax
32.6 Cr
Growth: -21.2%
Small Cap
655 Cr
P/E: 20.1x
Industry P/E: 29.6x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 373
Growth 17.7%
EBITDA 11.2%
P/S 1.8x
Dividend 0.1%
P/E 20.1x
Book Value ₹ 458
PEG Ratio 1.1x
ROE 11.9%
P/B 2.3x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Sep22Mar23Sep24
Promoters
Created with Highcharts 8.2.2Sep22Mar23Sep24
Others
Created with Highcharts 8.2.2Sep22Mar23Sep24
Increase    Decrease    No change
Company Profile Detailed

NGL Fine-chem is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It caters to various global companies to custom manufacture high quality pharmaceuticals with reliability and flexibility.Its business is modelled around the changing customer demands and their ability to offer value-added innovative solutions to meet and even exceed these demands.
Investors (3)
Followers (1)